Diagnosed With Diabetes After Taking Lipitor? Get Help Today!
Are you an older woman who is suffering from diabetes after taking Lipitor? If so, you are not alone. In fact, one medical study asserts that millions of women over age 46 who have taken Lipitor and similar cholesterol-lowering drugs face “a significantly increased risk of developing diabetes.”
The Driscoll Firm, LLC, wants to hear from you. Schedule a free review of your case today.
We currently are investigating potential Lipitor diabetes risk lawsuits from across the country. We are ready to stand by your side, protect your rights and seek compensation for any harm you have suffered.
What is Lipitor?
Lipitor is one of the top-selling drugs for its manufacturer, Pfizer, Inc. It belongs to a group of drugs called “statins.” These drugs lower cholesterol levels in one’s blood. But they also carry potential side effects.
Study Links Statin Drugs to Diabetes Risk in Older Women
A study by the University of Massachusetts Medical School, published in January 2012, found that post-menopausal women, ages 46 and older, who were taking statin drugs showed “a 48 percent increased rate of diabetes compared to those not on the cholesterol-lowering medications.”
FDA Orders Label Change
In February 2012, the FDA ordered a labeling change for statin drugs such as Lipitor. The FDA required the new labels to warn users of the potential risk of increased blood sugar levels and of being diagnosed with type 2 diabetes mellitus. For too many women, however, this warning may have come too late.
Get Started on Your Case Today
The Driscoll Firm, LLC, has a record of taking on major pharmaceutical companies and fighting for the rights of those harmed by dangerous drugs. Our goal is to hold drug manufacturers accountable for the undue physical, emotional and financial losses they cause innocent consumers.
Nationally recognized product liability attorney John J. Driscoll is particularly concerned about the potential diabetes risk being faced by older women who were prescribed Lipitor prior to the FDA’s February 2012 label change. He can review your case for free and assess your legal options.